NCT01883349View on ClinicalTrials.gov

Cognitive Impairment and Imaging Correlates in End Stage Renal Disease

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2023

Study Completion Date

September 30, 2023

Conditions
End Stage Renal Disease
Interventions
PROCEDURE

Kidney Transplant

Kidney Transplant Surgery

OTHER

No kidney transplant

The control group was made up of subjects without ESRD and were not on the renal transplantation waitlist.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER

NCT01883349 - Cognitive Impairment and Imaging Correlates in End Stage Renal Disease | Biotech Hunter | Biotech Hunter